Mehlika Toy

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. pmc The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country
    Mehlika Toy
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Dr Molewaterplein 50, 3000 CA, Rotterdam, The Netherlands
    Eur J Health Econ 13:663-76. 2012
  2. doi Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands
    M Toy
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Med Virol 80:399-404. 2008
  3. doi Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B
    Mehlika Toy
    Department of Public Health, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Hepatology 50:743-51. 2009
  4. pmc Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review
    Mehlika Toy
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Dr, Molewaterplein 50, 3000 CA Rotterdam, The Netherlands
    BMC Infect Dis 11:337. 2011
  5. doi Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective
    Irene K Veldhuijzen
    Division of Infectious Disease Control, Municipal Public Health Service Rotterdam Rijnmond, Rotterdam, The Netherlands
    Gastroenterology 138:522-30. 2010
  6. doi A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation
    Joost van Rosmalen
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Med Decis Making 33:767-79. 2013

Detail Information

Publications6

  1. pmc The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country
    Mehlika Toy
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Dr Molewaterplein 50, 3000 CA, Rotterdam, The Netherlands
    Eur J Health Econ 13:663-76. 2012
    ....
  2. doi Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands
    M Toy
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Med Virol 80:399-404. 2008
    ..The genotypes of the chronic HBV strains determined corresponded well with the HBV genotypes expected from the countries of origin of the patients or their mothers. Genotypes A and D are predominant in CHB patients in The Netherlands...
  3. doi Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B
    Mehlika Toy
    Department of Public Health, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Hepatology 50:743-51. 2009
    ..Conclusion: Long-term antiviral therapy with a strategy that minimizes or controls resistance will have a major preventive effect on liver-related mortality and morbidity...
  4. pmc Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review
    Mehlika Toy
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Dr, Molewaterplein 50, 3000 CA Rotterdam, The Netherlands
    BMC Infect Dis 11:337. 2011
    ..To provide a clear picture of the current hepatitis B situation, the authors performed a systematic review to estimate the age- and region-specific prevalence of chronic hepatitis B (CHB) in Turkey...
  5. doi Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective
    Irene K Veldhuijzen
    Division of Infectious Disease Control, Municipal Public Health Service Rotterdam Rijnmond, Rotterdam, The Netherlands
    Gastroenterology 138:522-30. 2010
    ..We assessed the cost-effectiveness in The Netherlands of systematically screening migrants from countries that have high and intermediate HBV infection levels...
  6. doi A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation
    Joost van Rosmalen
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Med Decis Making 33:767-79. 2013
    ..In conclusion, continuous-time Markov models are a feasible alternative to cohort analysis and can offer several theoretical and practical advantages. ..